PHILADELPHIA, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm, Berger Montague PC, informs investors that a lawsuit was filed against Assertio Holdings, Inc. ("Assertio") (NASDAQ:ASRT) on behalf of purchasers of Assertio's securities between March 9, 2023 and November 8, 2023, inclusive (the "Class Period").
Investors that suffered losses from Assertio Holdings, Inc. (NASDAQ:ASRT) investments can follow the link below for more information regarding the lawsuit:
CLICK HERE to learn more about the lawsuit.
Investors who purchased or acquired Assertio securities during the Class Period may, no later than March 5, 2024, seek to be appointed as a lead plaintiff representative of the class.
The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) Assertio's reliance on Indocin products to boost its net income was unsustainable given the risk of generic competition; (ii) Assertio's acquisition of Spectrum Pharmaceuticals, Inc. ("Spectrum Acquisition") was less valuable than Assertio had represented to ...
ASRT) Securities Fraud: Contact Berger Montague To Discuss Your Rights>Full story available on Benzinga.com